From Bio Co Ltd

From Bio Co Ltd exhibits a weak capital structure and liquidity position, with a debt-to-equity ratio of 1.26 and a current ratio of 0.49, indicating that the company's short-term liabilities exceed its short-term assets by a significant margin. The company's cash and equivalents of KRW 2,292,957,230 are insufficient to cover its long-term debt of KRW 35,411,182,120, resulting in a negative net cash position after subtracting total debt. This suggests a high dependency on external financing to maintain operations and meet obligations. The company's profitability is severely underperforming, with a return on equity of -0.8013 and a return on assets of -0.3442, both significantly below the industry median for Food Processing companies. These negative returns indicate that the company is not generating sufficient returns to cover its cost of capital or asset base. The operating loss of KRW -19,034,538,870 and net loss of KRW -22,457,152,320 further underscore the company's inability to generate positive earnings from its core operations. From Bio Co Ltd's revenue is concentrated in the health functional food segment, with disclosed products related to joint health, stomach health, eye health, and sleep health. The company also sells diet food, creams, shampoos, and soaps, but no specific revenue breakdown by segment is provided in the input data. The geographic exposure is primarily domestic, with no international revenue disclosed, which increases the company's vulnerability to local economic and regulatory changes. The company's growth trajectory is negative, with a net loss and declining operating cash flow. No specific revenue growth or decline percentages are provided for the current or next fiscal year, but the negative operating cash flow of KRW -10,071,951,270 and free cash flow of KRW -22,480,704,780 indicate a lack of cash generation to support expansion or debt servicing. The capital expenditure of KRW -1,266,798,530 suggests minimal investment in growth initiatives, further limiting the company's ability to improve its financial position. The company faces significant risk factors, including liquidity risk due to its negative net cash position and high debt-to-equity ratio. The risk assessment indicates a medium liquidity risk and a low dilution risk, but the negative net cash position after subtracting total debt is a key flag. The company has not disclosed any dilution sources in the input data, and no recent events such as filings or transcripts are provided to assess potential dilution pressures or strategic changes. No recent events, such as filings or transcripts, are provided in the input data to assess the company's recent strategic or operational developments. The absence of such information limits the ability to evaluate the company's response to its financial challenges or any new initiatives that may impact its future performance.